‘ME doesn’t mean all you need is a little bit of CBT and GET and you can get up and go’, Countess of Mar, 16 November 2010.
The Countess of Mar made another intervention during the House […]
Parliamentary Question: contacts between UNUM Provident, other insurers and Government departments, 16 November 2011
The Countess of Mar tabled a written question asking the
‘Lawsuit filed against chronic fatigue syndrome researcher by former employer’, ‘Science Insider’, 14 November 2011
From ‘Science Insider’, a Science magazine blog, 14 November 2011
Research: barriers to health care for children with chronic illness, BMC Health Services Research, 11 November 2011
From BMC Health Services Research, 11:308 doi:10.1186/1472-6963-11-308 (open access journal),
‘Private Eye’ piece on Unum, the American insurance company, and income protection cover, 11 November 2011
From ‘Private Eye’, In the Back section, 11 November 2011
GMC rules against Dr Andrew Wright, of Bolton, British Medical Journal, 8 November 2011
GMC rules against Dr Andrew Wright, of Bolton, British Medical Journal, 8 November 2011 Read More »
From the British Medical Journal, 8 November 2011 (story by
Comments by the Countess of Mar during debate at the committee stage of the Health and Social Care Bill, 7 November 2011
Committee (3rd Day) (Continued) Health and Social Care Bill Hansard
‘Dr Ian Lipkin and Dr Mady Hornig use deep sequencing and proteomics to hunt CFS viruses’, Cure talk website, 4 November 2011
From the ‘Cure Talk: conversations about new treatments and clinical
Parliamentary Question: national commissioning of treatment for M.E., 3 November 2011
Parliamentary Question: national commissioning of treatment for M.E., 3 November 2011 Read More »
A question asking the Secretary of State for Health what
‘Helping my sick daughter die was worst heartbreak a mother can face’, Evening Herald, Ireland, 2 November 2011
From the Evening Herald, Ireland, 2 November 2011 (story by
Research: social support needs of people with ME/CFS, 2 November 2011
Research: social support needs of people with ME/CFS, 2 November 2011 Read More »
From the International Journal for Equity in Health,10:46 doi:10.1186/1475-9276-10-46, 2
Fluge and Mella respond to van de Meer about rituximab, letter to PlosOne, 31 October 2011
From PlosOne, 31 October, where the full range of letters
‘Rituximab basics with Dr John Sweetenham’, Research 1st website, 30 October 2011
‘Rituximab basics with Dr John Sweetenham’, Research 1st website, 30 October 2011 Read More »
From ‘Research 1st’, a website maintained by the CFIDS Association
Concerns about rituximab study, letters to PloSOne, 27 October 2011
Concerns about rituximab study, letters to PloSOne, 27 October 2011 Read More »
Original paper in PLoSOne, 27 October 2011. Rituximab in CFS;
Research: Literature review of complementary and alternative medicine used in ME/CFS, 7 October 2011
From BMC Complementary and Alternative Medicine, 7 October 2011. Complementary
Scottish Parliament Answers to Kezia Dugdale MSP, 26 October 2011
Scottish Parliament Answers to Kezia Dugdale MSP, 26 October 2011 Read More »
Kezia Dugdale, Scottish Labour MSP for Lothian, received answers to
UK insurance industry gets to hear about the rituximab clinical trial, 26 October 2011
UK insurance industry gets to hear about the rituximab clinical trial, 26 October 2011 Read More »
From USay Compare, Health Insurance News, 26 Octoberr 2011 Health
‘CFS – a treatable autoimmune disease’, Huffington Post Online, 26 October 2011
‘CFS – a treatable autoimmune disease’, Huffington Post Online, 26 October 2011 Read More »
From Huffington Post Online, AOL Health News, 26 October 2011
‘Rituximab and the Press’, the CFS Patient Advocate blog, 24 October 2011
‘Rituximab and the Press’, the CFS Patient Advocate blog, 24 October 2011 Read More »
From the blog run by the ‘CFS Patient Advocate’, 24
ABC News in the States cover the Rituximab story, 24 October 2011
ABC News in the States cover the Rituximab story, 24 October 2011 Read More »
From ABC News, 24 October 2011 (story by Katie Moisse)